Long-term physico-chemical stability of 5-fluorouracile at standardised rounded doses (SRD) in MyFuser® portable infusion pump.


Journal

Journal of chemotherapy (Florence, Italy)
ISSN: 1973-9478
Titre abrégé: J Chemother
Pays: England
ID NLM: 8907348

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 10 4 2021
medline: 27 1 2022
entrez: 9 4 2021
Statut: ppublish

Résumé

Management of chemotherapies is a strategic issue for european healthcare. Dose-banding enables to reduce waiting time of patients in day care units and drug wastage. The aim of this study was to assess the stability of 5-Fluorouracile (5-FU) at standardised rounded doses of 4 and 5 g in MyFuser® portable infusion pump for in-advance preparation. Ten MyFuser® (4 and 5 gr 5-FU added to NaCl 0.9%) were prepared under aseptic conditions and stored at room temperature (23 ± 2 °C) for 28 days then at 30 °C for three days. Physical stability tests were periodically performed: visual and microscopic inspection, pH measurements and optical densities. The concentration of solutions was measured by High Performance Liquid Chromatography/UV detector. Results confirm the stability of 5-FU at selected SRD of 4 g and 5 g with NaCl 0.9% in MyFuser® for at least 28 days at room temperature and three days at 30 °C, allowing in-advance preparation.

Identifiants

pubmed: 33835887
doi: 10.1080/1120009X.2021.1906037
doi:

Substances chimiques

Antimetabolites, Antineoplastic 0
Fluorouracil U3P01618RT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

486-491

Auteurs

Mélanie Closset (M)

Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Sabrina Onorati (S)

Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.

Marie-Lise Colsoul (ML)

Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Nicolas Goderniaux (N)

Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Benoît Bihin (B)

Scientific Support Unit, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Jacques Jamart (J)

Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Laura Soumoy (L)

Department of Pharmacy, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Jean-Daniel Hecq (JD)

Department of Pharmacy, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Pascal Odou (P)

CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Université de Lille, Lille, France.

Laurence Galanti (L)

Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH